Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers

Michael Roerecke, Jürgen Rehm, Michael Roerecke, Jürgen Rehm

Abstract

Background: Alcohol consumption is a major global risk factor for mortality and morbidity. Much discussion has revolved around the diverse findings on the complex relationship between alcohol consumption and the leading cause of death and disability, ischemic heart disease (IHD).

Methods: We conducted a systematic search of the literature up to August 2014 using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to identify meta-analyses and observational studies examining the relationship between alcohol drinking, drinking patterns, and IHD risk, in comparison to lifetime abstainers. In a narrative review we have summarized the many meta-analyses published in the last 10 years, discussing the role of confounding and experimental evidence. We also conducted meta-analyses examining episodic heavy drinking among on average moderate drinkers.

Results: The narrative review showed that the use of current abstainers as the reference group leads to systematic bias. With regard to average alcohol consumption in relation to lifetime abstainers, the relationship is clearly J-shaped, supported by short-term experimental evidence and similar associations within strata of potential confounders, except among smokers. Women experience slightly stronger beneficial associations and also a quicker upturn to a detrimental effect at lower levels of average alcohol consumption compared to men. There was no evidence that chronic or episodic heavy drinking confers a beneficial effect on IHD risk. People with alcohol use disorder have an elevated risk of IHD (1.5- to 2-fold). Results from our quantitative meta-analysis showed that drinkers with average intake of <30 g/day and no episodic heavy drinking had the lowest IHD risk (relative risk = 0.64, 95% confidence interval 0.53 to 0.71). Drinkers with episodic heavy drinking occasions had a risk similar to lifetime abstainers (relative risk = 1.12, 95% confidence interval 0.91 to 1.37).

Conclusions: Epidemiological evidence for a beneficial effect of low alcohol consumption without heavy drinking episodes is strong, corroborated by experimental evidence. However, episodic and chronic heavy drinking do not provide any beneficial effect on IHD. Thus, average alcohol consumption is not sufficient to describe the risk relation between alcohol consumption and IHD. Alcohol policy should try to reduce heavy drinking patterns.

Figures

Figure 1
Figure 1
The association of ischemic heart disease mortality with average alcohol consumption in comparison to lifetime abstention in men. Data points taken from published meta-analyses [15,33,39]. All point estimates and confidence intervals were obtained from categorical meta-analyses stratified by alcohol exposure. The Russian estimates were pooled from Zaridze et al. [40,41].
Figure 2
Figure 2
Ischemic heart disease incidence by drinking pattern among drinkers with average consumption of <30 g/day in comparison to lifetime abstention. Please see Additional file 1: Table S1, Figures S3 and S4 for details. †Taken from Roerecke & Rehm [26].

References

    1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, 3rd, Moy CS, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129:e28–e292.
    1. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe: epidemiological update. Eur Heart J. 2013;34:3028–3034.
    1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128.
    1. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–2223.
    1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–2260.
    1. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol use disorders. Lancet. 2009;373:2223–2233.
    1. International Agency for Research on Cancer . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Alcohol Consumption and Ethyl Carbamate. Lyon, France: International Agency for Research on Cancer; 2010.
    1. International Agency for Research on Cancer . Personal Habits and Indoor Combustions. Lyon, France: International Agency for Research on Cancer; 2012.
    1. Rehm J, Shield K. Alcohol consumption. In: Steward BW, Wild CP, editors. World Cancer Report. Lyon: International Agency for Research on Cancer; 2014. pp. 97–1070.
    1. Rehm J, Shield KD. Alcohol and mortality. Global alcohol-attributable deaths from cancer, liver cirrhosis, and injury in 2010. Alcohol Res. 2013;35:174–183.
    1. Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59:160–168.
    1. Fekjaer HO. Alcohol—a universal preventive agent? A critical analysis. Addiction. 2013;108:2051–2057.
    1. Jackson R, Broad J, Connor J, Wells S. Alcohol and ischaemic heart disease: probably no free lunch. Lancet. 2005;366:1911–1912.
    1. Goldberg IJ. To drink or not to drink? N Engl J Med. 2003;348:163–164.
    1. Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction. 2012;107:1246–1260.
    1. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction. 2000;95:1505–1523.
    1. Maclure M. Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol Rev. 1993;15:328–351.
    1. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.
    1. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 2011;342:d636.
    1. Rimm EB, Williams P, Fosher K, Criqui MH, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999;19:1523–1528.
    1. Seppä K, Sillanaukee P, Pitkäjärvi T, Nikkilä M, Koivula T. Moderate and heavy alcohol consumption have no favorable effect on lipid values. Arch Intern Med. 1992;152:297–300.
    1. Wakabayashi I. Associations between alcohol drinking and multiple risk factors for atherosclerosis in smokers and nonsmokers. Angiology. 2010;61:495–503.
    1. Chikritzhs T, Fillmore K, Stockwell T. A healthy dose of scepticism: four good reasons to think again about protective effects of alcohol on coronary heart disease. Drug Alcohol Rev. 2009;28:441–444.
    1. Hill A. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.
    1. Shaper A, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet. 1988;2:1267–1273.
    1. Roerecke M, Rehm J. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am J Epidemiol. 2010;171:633–644.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, The Prisma Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med. 2009;6:e1000097.
    1. Hamling J, Lee P, Weitkunat R, Ambühl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med. 2008;27:954–970.
    1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.
    1. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–129.
    1. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558.
    1. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
    1. Roerecke M, Rehm J. Ischemic heart disease mortality and morbidity in former drinkers: a meta-analysis. Am J Epidemiol. 2011;73:245–258.
    1. Rogers RG, Krueger PM, Miech R, Lawrence EM, Kemp R. Nondrinker mortality risk in the United States. Popul Res Policy Rev. 2013;32:325–352.
    1. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med. 1990;322:95–99.
    1. Kwo PY, Pamchandani VA, O’Connor S, Amann D, Carr LG, Sandrasegaran K, Kopecky KK, Li TK. Gender differences in alcohol metabolism: relationship to liver volume and effect of adjusting for body mass. Gastroenterology. 2012;115:1552–1557.
    1. Meister KA, Whelan EM, Kava R. The health effects of moderate alcohol intake in humans: an epidemiologic review. Crit Rev Clin Lab Sci. 2000;37:261–296.
    1. Bagnardi V, Zatonski W, Scotti L, La Vecchia C, Corrao G. Does drinking pattern modify the effect of alcohol on the risk of coronary heart disease? Evidence from a meta-analysis. J Epidemiol Community Health. 2008;62:615–619.
    1. Roerecke M, Rehm J: Chronic heavy drinking and ischaemic heart disease: a systematic review and meta-analysis.Open Heart 2014, 1:. doi:10.1136/openhrt-2014-000135.
    1. Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A, Konobeevskaya I, Igitov V, Terechova T, Boffetta P, Peto R. Alcohol and cause-specific mortality in Russia: a retrospective case–control study of 48,557 adult deaths. Lancet. 2009;373:2201–2214.
    1. Zaridze D, Lewington S, Boroda A, Scélo G, Karpov R, Lazarev A, Konobeevskaya I, Igitov V, Terechova T, Boffetta P, Sherliker P, Kong X, Whitlock G, Boreham J, Brennan P, Peto R. Alcohol and mortality in Russia: prospective observational study of 151,000 adults. Lancet. 2014;383:1465–1473.
    1. Roerecke M, Rehm J. Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and meta-analysis. Int J Epidemiol. 2014;43:906–919.
    1. Rehm J, Gmel G, Sempos C, Trevisan M. Alcohol-related mortality and morbidity. Alcohol Res Health. 2003;27:39–51.
    1. Puddey IB, Rakic V, Dimmitt SB, Beilin LJ. Influence of pattern of drinking on cardiovascular disease and cardiovascular risk factors - a review. Addiction. 1999;94:649–663.
    1. McKee M, Britton A. The positive relationship between alcohol and heart disease in Eastern Europe: potential physiological mechanisms. J R Soc Med. 1998;91:402–407.
    1. McElduff P, Dobson AJ. How much alcohol and how often? Population based case–control study of alcohol consumption and risk of a major coronary event. BMJ. 1997;314:1159–1164.
    1. Ruidavets JB, Ducimetière P, Evans A, Montaye M, Haas B, Bingham A, Yarnell J, Amouyel P, Arveiler D, Kee F, Bongard V, Ferrières J. Patterns of alcohol consumption and ischaemic heart disease in culturally divergent countries: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) BMJ. 2010;341:c6077.
    1. Malyutina S, Bobak M, Kurilovitch S, Gafarov V, Simonova G, Nikitin Y, Marmot M. Relation between heavy and binge drinking and all-cause and cardiovascular mortality in Novosibirski, Russia: a prospective cohort study. Lancet. 2002;360:1448–1454.
    1. Leon DA, Shkolnikov VM, McKee M, Kiryanov N, Andreev E. Alcohol increases circulatory disease mortality in Russia: acute and chronic effects or misattribution of cause? Int J Epidemiol. 2010;39:1279–1290.
    1. Sidorenkov O, Nilssen O, Grjibovski AM. Determinants of cardiovascular and all-cause mortality in northwest Russia: a 10-year follow-up study. Ann Epidemiol. 2012;22:57–65.
    1. Tomkins S, Saburova L, Kiryanov N, Andreev E, McKee M, Shkolnikov V, Leon DA. Prevalence and socio-economic distribution of hazardous patterns of alcohol drinking: study of alcohol consumption in men aged 25–54 years in Izhevsk. Russia Addict. 2007;102:544–553.
    1. Rostron B. Alcohol consumption and mortality risks in the USA. Alcohol Alcohol. 2012;47:334–339.
    1. Hvidtfeldt UA, Tolstrup JS, Jakobsen MU, Heitmann BL, Grønbaek M, O'Reilly E, Bälter K, Goldbourt U, Hallmans G, Knekt P, Liu S, Pereira M, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Rimm EB, Ascherio A. Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults. Circulation. 2010;121:1589–1597.
    1. Bazzano LA, Gu DF, Reynolds K, Chen J, Wu XQ, Chen CS, Duan XF, Chen JC, He J. Alcohol consumption and risk of coronary heart disease among Chinese men. Int J Cardiol. 2009;135:78–85.
    1. Doll R, Peto R, Hall E, Wheatley K, Gray R. Mortality in relation to consumption of alcohol: 13 years’ observations on male British doctors. BMJ. 1994;309:911–918.
    1. Miyake Y. Risk factors for non-fatal acute myocardial infarction in middle-aged and older Japanese. Fukuoka Heart Study Group. Jpn Circ J. 2000;64:103–109.
    1. Oliveira A, Barros H, Azevedo A, Bastos J, Lopes C. Impact of risk factors for non-fatal acute myocardial infarction. Eur J Epidemiol. 2009;24:425–432.
    1. Goldberg RJ, Burchfield CM, Reed DM, Wergowske G, Chiu D. A prospective study of the health effects of alcohol consumption in middle-aged and elderly men: the Honolulu Heart Program. Circulation. 1994;89:651–659.
    1. Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659–669.
    1. Inoue M, Nagata C, Tsuji I, Sugawara Y, Wakai K, Tamakoshi A, Matsuo K, Mizoue T, Tanaka K, Sasazuki S, Tsugane S, Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan Impact of alcohol intake on total mortality and mortality from major causes in Japan: a pooled analysis of six large-scale cohort studies. J Epidemiol Community Health. 2012;66:448–456.
    1. Hart CL, Davey Smith G, Gruer L, Watt GC. The combined effect of smoking tobacco and drinking alcohol on cause-specific mortality: a 30 year cohort study. BMC Public Health. 2010;10:789.
    1. Ebbert JO, Janney CA, Sellers TA, Folsom AR, Cerhan JR. The association of alcohol consumption with coronary heart disease mortality and cancer incidence varies by smoking history. J Gen Intern Med. 2005;20:14–20.
    1. Friedman LA, Kimball AW. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol. 1986;124:481–489.
    1. Shaper AG, Phillips AN, Pocock SJ, Walker M. Alcohol and ischemic heart disease in middle-aged British men. BMJ. 1987;294:733–737.
    1. Garg R, Wagener DK, Madans JH. Alcohol consumption and risk of ischemic heart disease in women. Arch Intern Med. 1993;153:1211–1216.
    1. Pedersen JØ, Heitmann BL, Schnohr P, Grønbaek M. The combined influence of leisure-time physical activity and weekly alcohol intake on fatal ischaemic heart disease and all-cause mortality. Eur Heart J. 2008;29:204–212.
    1. Pai JK, Mukamal KJ, Rimm EB. Long-term alcohol consumption in relation to all-cause and cardiovascular mortality among survivors of myocardial infarction: the Health Professionals Follow-up Study. Eur Heart J. 2012;33:1598–1605.
    1. Jackson VA, Sesso HD, Buring JE, Gaziano JM. Alcohol consumption and mortality in men with preexisting cerebrovascular disease. Arch Intern Med. 2003;163:1189–1193.
    1. Tanasescu M, Hu FB, Willett WC, Stampfer MJ, Rimm EB. Alcohol consumption and risk of coronary heart disease among men with type 2 diabetes mellitus. J Am Coll Cardiol. 2001;38:1836–1842.
    1. Solomon CG, Hu FB, Stampfer MJ, Colditz GA, Speizer FE, Rimm EB, Willett WC, Manson JE. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation. 2000;102:494–499.
    1. Beulens JW, Rimm EB, Stampfer MJ, Ascherio A, Hendriks HF, Mukamal KJ. Alcohol consumption and risk of coronary heart disease in men with hypertension. Ann Intern Med. 2007;146:10–19.
    1. Beulens JW, Algra A, Soedamah-Muthu SS, Visseren FL, Grobbee DE, van der Graaf Y, SMART Study Group Alcohol consumption and risk of recurrent cardiovascular events and mortality in patients with clinically manifest vascular disease and diabetes mellitus: the Second Manifestations of ARTerial (SMART) disease study. Atherosclerosis. 2010;212:281–286.
    1. Britton KA, Gaziano JM, Sesso HD, Djoussé L. Relation of alcohol consumption and coronary heart disease in hypertensive male physicians (from the Physicians’ Health Study) Am J Cardiol. 2009;104:932–935.
    1. Mukamal KJ, Chiuve SE, Rimm EB. Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Arch Intern Med. 2006;166:2145–2150.
    1. Britton A, Marmot MG, Shipley M. Who benefits most from the cardioprotective properties of alcohol consumption–health freaks or couch potatoes? J Epidemiol Community Health. 2008;62:905–908.
    1. Brinton EA. Effects of ethanol intake on lipoproteins. Curr Atheroscler Rep. 2012;14:108–114.
    1. Contaldo F, D’Arrigo E, Carandente V, COrtese C, Coltori A, Mancini M, Taskinen MR, Nikkilä EA. Short-term effects of moderate alcohol consumption on lipid metabolism and energy balance in normal men. Metabolism. 1989;38:166–171.
    1. Malmendier CL, Delcroix C. Effect of alcohol intake on high and low density lipoprotein metabolism in healthy volunteers. Clin Chem Acta. 1985;152:281–288.
    1. Crouse JR, Grundy SM. Effects of alcohol on plasma lipoproteins and cholesterol and triglyceride metabolism in man. J Lipid Res. 1984;25:486–496.
    1. Belfrange P, Berg B, Cronholm T, Elmqvist D, Hagerstrand I, Johansson B, Nilsson-Ehle P, Nordén G, Sjövall J, Wiebe T. Prolonged administration of ethanol to young, healthy volunteers: effects on biochemical, morphological and neurophysiological parameters. Acta Med Scand. 1973;552:1–44.
    1. Belfrage P, Berg B, Hagerstrand I, Nilsson-Ehle P, Tornqvist H, Wiebe T. Alterations of lipid metabolism in healthy volunteers during long-term ethanol intake. Eur J Clin Invest. 1977;7:127–131.
    1. Välimäki M, Laitinen K, Ylikahri R, Ehnholm C, Jauhianen M, Bard JM, Fruchart JC, Taskinen MR. The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein (a) Metabolism. 1991;40:1168–1172.
    1. Peasey A, Bobak M, Malyutina S. Do lipids contribute to the lack of cardio-protective effect of binge drinking: alcohol consumption and lipids in three eastern European countries. Alcohol Alcohol. 2005;40:431–435.
    1. Hillbom M, Saloheimo P, Juvela S. Alcohol consumption, blood pressure, and the risk of stroke. Curr Hypertens Rep. 2011;13:208–213.
    1. Rakic V, Puddey IB, Burke V, Dimmitt SB, Beilin LJ. Influence of pattern of alcohol intake on blood pressure in regular drinkers: a controlled trial. J Hypertens. 1998;16:165–174.
    1. Marmot MG, Elliott P, Shipley MJ, Dyer AR, Ueshima H, Beevers DG, Stamler R, Kesteloot H, Rose G, Stamler J. Alcohol and blood pressure: the INTERSALT study. BMJ. 1994;308:1263–1267.
    1. Pajak A, Szafraniec K, Kubinova R, Malyutina S, Peasey A, Pikhart H, Nikitin Y, Marmot M, Bobak M. Binge drinking and blood pressure: cross-sectional results of the HAPIEE study. PLoS One. 2013;8:e65856.
    1. Seppa K, Sillanaukee P. Binge drinking and ambulatory blood pressure. Hypertension. 1999;33:79–82.
    1. Zakhari S. Alcohol and the cardiovascular system: molecular mechanisms for beneficial and harmful action. Alcohol Res Health. 1997;21:21–29.
    1. Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, Rehm J. Alcohol and hypertension: gender differences in dose–response relationships determined through systematic review and meta-analysis. Addiction. 2009;104:1981–1990.
    1. Britton A, McKee M. The relation between alcohol and cardiovascular disease in Eastern Europe: explaining the paradox. J Epidemiol Community Health. 2000;54:328–332.
    1. Menezes AR, Lavie CJ, DiNicolantonio JJ, O’Keefe J, Morin DP, Khatib S, Milani RV. Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies. Mayo Clin Proc. 2013;88:394–409.
    1. Samokhvalov AV, Irving HM, Rehm J. Alcohol as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil. 2010;17:706–712.
    1. Di Minno MN, Franchini M, Russolillo A, Lupoli R, Iervolino S, Di Minno G. Alcohol dosing and the heart: updating clinical evidence. Semin Thromb Hemost. 2011;37:875–884.
    1. Holmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, Prieto-Merino D, Dehghan A, Trompet S, Wong A, Cavadino A, Drogan D, Padmanabhan S, Li S, Yesupriya A, Leusink M, Sundstrom J, Hubacek JA, Pikhart H, Swerdlow DI, Panayiotou AG, Borinskaya SA, Finan C, Shah S, Kuchenbaecker KB, Shah T, Engmann J, Folkersen L, Eriksson P, Ricceri F, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:g4164.
    1. Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Res Health. 2006;29:245–254.
    1. Rehm J, Roerecke M: Time to rethink the ischaemic heart disease effects of low to moderate alcohol consumption?BMJ 2014, ᅟ:ᅟ. .
    1. Eckardt M, File S, Gessa G, Grant K, Guerri C, Hoffman P, Kalant H, Koop G, Li T, Tabakoff B. Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res. 1998;22:998–1040.
    1. Shield K, Rylett M, Gmel G, Gmel G, Kehoe-Chan T, Rehm J. Global alcohol exposure estimates by country, territory and region for 2005 – a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. Addiction. 2013;108:912–922.
    1. Center for Disease Control and Prevention Vital signs: binge drinking prevalence, frequency, and intensity among adults—U.S., 2010. MMWR Morb Mortal Wkly Rep. 2012;61:14–19.
    1. Serdula MK, Brewer RD, Gillespie C, Denny CH, Mokdad A. Trends in alcohol use and binge drinking, 1985–1999: results of a multi-state survey. Am J Prev Med. 2004;26:294–298.
    1. Naimi TS, Brewer RD, Mokdad A, Denny C, Serdula MK, Marks JS. Binge drinking among US adults. JAMA. 2003;289:70–75.
    1. Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Alteri A, Cogliano V, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group Carcinogenicity of alcoholic beverages. Lancet Oncol. 2007;8:292–293.
    1. Babor T, Caetano R, Casswell S, Edwards G, Giesbrecht N, Graham K, Grube J, Gruenewald P, Hill L, Holder H, Homel R, Livingston M, Osterberg E, Rehm J, Room R, Rossow I. Alcohol: No Ordinary Commodity. Research and Public Policy. 2. Oxford: Oxford University Press; 2010.
    1. Room R, Babor T, Rehm J. Alcohol and public health: a review. Lancet. 2005;365:519–530.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться